150 related articles for article (PubMed ID: 11361450)
1. Ganciclovir prophylaxis for CMV disease infrequently associated with viral resistance.
AIDS Patient Care; 1995 Dec; 9(6):308. PubMed ID: 11361450
[No Abstract] [Full Text] [Related]
2. Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus disease.
Jacobson MA
Scand J Infect Dis Suppl; 1995; 99():96-9. PubMed ID: 8668951
[TBL] [Abstract][Full Text] [Related]
3. Oral ganciclovir shows benefit for prevention of CMV disease in liver transplant recipients.
J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):43-4. PubMed ID: 11363747
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 12 Suppl 1():S1-22. PubMed ID: 8680897
[No Abstract] [Full Text] [Related]
5. Oral ganciclovir as prophylaxis against cytomegalovirus.
Wood CA
N Engl J Med; 1996 Oct; 335(18):1395; author reply 1396-7. PubMed ID: 8927069
[No Abstract] [Full Text] [Related]
6. Oral ganciclovir.
Schouten JT
STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
8. CMV drug approved.
Treat Rev; 1995 Nov; (no 20):5. PubMed ID: 11363026
[TBL] [Abstract][Full Text] [Related]
9. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
[TBL] [Abstract][Full Text] [Related]
10. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M
Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408
[TBL] [Abstract][Full Text] [Related]
11. CMV news.
Posit Aware; 1996; 7(1):5-6. PubMed ID: 11363124
[TBL] [Abstract][Full Text] [Related]
12. Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?
Singh N; Yu VL
Dig Dis Sci; 1998 Jun; 43(6):1190-2. PubMed ID: 9635606
[No Abstract] [Full Text] [Related]
13. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir for cytomegalovirus infection.
Am Fam Physician; 1996 Mar; 53(4):1441. PubMed ID: 8629579
[No Abstract] [Full Text] [Related]
15. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir.
Imai Y; Shum C; Martin DF; Kuppermann BD; Drew WL; Margolis TP
J Infect Dis; 2004 Feb; 189(4):611-5. PubMed ID: 14767813
[TBL] [Abstract][Full Text] [Related]
16. Ganciclovir approved to prevent CMV.
Gilden D
GMHC Treat Issues; 1995 Nov; 9(11):3. PubMed ID: 11362989
[TBL] [Abstract][Full Text] [Related]
17. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
Murray BM; Subramaniam S
Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.
Razonable RR; van Cruijsen H; Brown RA; Wilson JA; Harmsen WS; Wiesner RH; Smith TF; Paya CV
J Infect Dis; 2003 Jun; 187(11):1801-8. PubMed ID: 12751039
[TBL] [Abstract][Full Text] [Related]
19. CMV resistance: "more complicated than we thought".
Mascolini M
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):37-9. PubMed ID: 11363529
[TBL] [Abstract][Full Text] [Related]
20. Oral ganciclovir as prophylaxis against cytomegalovirus.
Pulido F; Carnevali D; Rubio R
N Engl J Med; 1996 Oct; 335(18):1396; author reply 1396-7. PubMed ID: 8927070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
